• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology,...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 23, 2024 at 09:52: PM
via Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that it has obtained an exclusive license from TreeFrog Therapeutics, a French-based biotech company, to its proprietary cell manufacturing technology, C-Stem, to optimize production of Vertex's cell therapies for type 1 diabetes or T1D.

article source
 

<



Similar threads

cafead
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength
Replies
0
Views
106
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Led by Merck, Vertex and Lilly, pharma&#039;s share prices largely climbed in &#039;22...
Replies
0
Views
124
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vertex Pharma (VRTX) to Acquire ViaCyte for $320 Million
Replies
0
Views
140
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, rivaling some male Big Pharma peers
Replies
1
Views
264
Pharma/Biotech Companies - In the News
anonymous
cafead
Vertex Pharma Tops Quarterly Views On Strong Cystic Fibrosis Drug Sales
Replies
0
Views
138
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote